Prof. Dr. VOLKAN DEMİRHAN YUMUK

Yayın Ağı

Makaleler 81

1. GLP-1 RECEPTOR ANALOGS-EVIDENCE LINKING TO EFFECT ON METABOLIC AND REPRODUCTIVE FUNCTIONS IN PATIENTS WITH PCOS AND OBESITY.

Celik O., Yazici D., Ciudin A., Macut D., Micic D., Yumuk V. D., et al.

Obesity facts , cilt.19, sa.1, ss.93-108, 2026 (SCI-Expanded, Scopus)

2. Prevalence of MASLD and fibrosis in Turkey: Results from a multicenter study of at-risk populations

Dogay Us G., Innocenti F., Koc O. M., YUMUK V. D., GÜNGÖR Z. B., Koek G. H.

PLOS ONE , cilt.21, sa.2 February, 2026 (SCI-Expanded, Scopus)

3. Mediterranean and low-fat diets are equally effective in MASLD resolution at 12 weeks regardless of PNPLA3 genotype: A randomized controlled trial.

Dogay Us G., Innocenti F., Koc O. M., Alagoz A. E., Yumuk V. D., Gungor Z. B., et al.

Hepatology communications , cilt.9, sa.12, 2025 (SCI-Expanded, Scopus)

4. The Integration of Lifestyle Modification Advice and Diet and Physical Exercise Interventions: Cornerstones in the Management of Obesity with Incretin Mimetics.

Minnetti M., Barazzoni R., Batsis J. A., Busetto L., Yumuk V. D., Poggiogalle E., et al.

Obesity facts , ss.1-16, 2025 (SCI-Expanded, Scopus)

5. To What Extent Do Clinical Practice Guidelines for Chronic Diseases Embrace Current Obesity Management Guidance? A Qualitative Content Analysis.

Ramos Salas X., Hussey B., Birney S., Breen C., Crotty M., Järvholm K., et al.

Obesity facts , ss.1-17, 2025 (SCI-Expanded, Scopus)

6. American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease - 2025 Update.

Nadolsky K., Garvey W. T., Agarwal M., Bonnecaze A., Burguera B., Chaplin M. D., et al.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists , cilt.31, ss.1351-1394, 2025 (SCI-Expanded, Scopus)

7. Comprehensive analysis of real-world data on liraglutide treatment in patients with obesity: a multicenter national study.

Hepşen S., Haymana C., Cavnar Helvacı B., Durantaş H., Toros B., Çakmak R., et al.

European journal of medical research , cilt.30, sa.1, ss.956, 2025 (SCI-Expanded, Scopus)

8. Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO).

McGowan B., Ciudin A., Baker J. L., Busetto L., Dicker D., Frühbeck G., et al.

Nature medicine , 2025 (SCI-Expanded, Scopus)

9. A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults.

McGowan B., Ciudin A., Baker J. L., Busetto L., Dicker D., Frühbeck G., et al.

Nature medicine , cilt.31, ss.3317-3329, 2025 (SCI-Expanded, Scopus)

10. The impact of sarcopenic obesity on cancer clinical outcomes

Köylü B., Sulu C., YUMUK V. D., Yumuk P. F.

Seminars in Cancer Biology , cilt.114, ss.203-214, 2025 (SCI-Expanded, Scopus)

11. ACTION Teens Global Survey-Türkiye Report: More Worry and Less Motivation for Adolescents Living with Obesity.

Bereket A., Perdahlı Fiş N., Gürser B., Hatun Ş., Sakarya S., Yumuk V. D., et al.

Journal of clinical research in pediatric endocrinology , cilt.17, ss.307-317, 2025 (SCI-Expanded, Scopus, TRDizin)

12. Development of the European Association for the Study of Obesity (EASO) Grade-Based Framework on the Pharmacological Treatment of Obesity: Design and Methodological Aspects.

McGowan B., Ciudin A., Baker J. L., Busetto L., Dicker D., Frühbeck G., et al.

Obesity facts , cilt.19, sa.1, ss.84-92, 2025 (SCI-Expanded, Scopus)

13. Impact of obesity on metabolic control in type 2 diabetes: Five-year trends of Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes (TEMD Obesity Study, 2017-2022).

Kiyici S., Demirci I., Sonmez A., Haymana C., Mert M., Nuhoglu I., et al.

Obesity facts , ss.1-15, 2025 (SCI-Expanded, Scopus)

14. Türkiye Consensus Report on the Multidisciplinary Obesity Treatment in Adults.

Sonmez A., Bayram F., Banli O., Demirci I., Kiyici S., Kucuk Yetgin M., et al.

Obesity facts , ss.1-20, 2025 (SCI-Expanded, Scopus)

15. Providing a common language for obesity: the European Association for the Study of Obesity obesity taxonomy

Bowman-Busato J., Schreurs L., Halford J. C. G., YUMUK V. D., O’Malley G., Woodward E., et al.

International Journal of Obesity , cilt.49, sa.2, ss.182-191, 2025 (SCI-Expanded, Scopus)

16. European recommendations from health care professionals and people living with obesity on safe practice for bariatric and metabolic surgery medical tourism: a modified delphi consensus statement from EASO, IFSO-EC and ECPO.

Dobbie L. J., Birney S., Breen C., Bryant S., Clare K., Ciudin A., et al.

International journal of surgery (London, England) , 2024 (SCI-Expanded, Scopus)

17. Annual health expenditures by body mass index categories and the economic impact of obesity in Türkiye: A retrospective modeling study.

Oksuz E., Malhan S., Alis H., GogasYavuz D., Karakan T., Sargin M., et al.

Obesity facts , ss.1-29, 2024 (SCI-Expanded, Scopus)

18. Pharmacotherapy for older people with obesity

Boyle L. D., Akbas F., Yazıcı D., McGowan B. M., YUMUK V. D.

European Journal of Internal Medicine , cilt.130, ss.33-37, 2024 (SCI-Expanded, Scopus)

19. "Obesity management in the older age, new understanding for old challenges"

Dicker D., ÇALIK BAŞARAN N., YUMUK V. D.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , ss.1-2, 2024 (SCI-Expanded, Scopus)

20. European Association for the Study of Obesity (EASO) Position Statement on Medical Nutrition Therapy for the Management of Individuals with Overweight or Obesity and Cancer

Muscogiuri G., Barrea L., Bettini S., El Ghoch M., Katsiki N., Tolvanen L., et al.

Obesity Facts , cilt.18, sa.1, ss.86-105, 2024 (SCI-Expanded, Scopus)

21. Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group.

Janez A., Muzurovic E., Bogdanski P., Czupryniak L., Fabryova L., Fras Z., et al.

Diabetes therapy : research, treatment and education of diabetes and related disorders , cilt.15, sa.9, ss.1865-1892, 2024 (SCI-Expanded, Scopus)

22. A new framework for the diagnosis, staging and management of obesity in adults.

Busetto L., Dicker D., Frühbeck G., Halford J. C. G., Sbraccia P., Yumuk V. D., et al.

Nature medicine , 2024 (SCI-Expanded, Scopus)

23. SHORT HISTORY OF OBESITY.

Micic D., Polovina S., Micic D., Yumuk V. D.

Acta endocrinologica (Bucharest, Romania : 2005) , cilt.20, sa.2, ss.207-211, 2024 (SCI-Expanded, Scopus)

24. Barriers to Obesity Management in Primary Health-Care

Yazıcı D., Ertınmaz B., Erden N., Gönenli M. G., Sargın M., Akbaş F., et al.

Endocrinology Research and Practice , cilt.28, sa.2, ss.82-86, 2024 (ESCI, Scopus, TRDizin)

25. Expert Opinion on the Utility of Telemedicine in Obesity Care: Recommendations on a Hybrid Multidisciplinary Integrated Care Follow-Up Algorithm

Bayram F., Sonmez A., Kiyici S., Akbas F., Yetgin M. K., Yazici D., et al.

Current Obesity Reports , cilt.13, sa.1, ss.167-182, 2024 (SCI-Expanded, Scopus)

26. Treat Obesity to Treat Type 2 Diabetes Mellitus.

Sulu C., Yumuk V. D.

Diabetes therapy : research, treatment and education of diabetes and related disorders , cilt.15, ss.611-622, 2024 (SCI-Expanded, Scopus)

27. Obesogenic environments as major determinants of a disease: It is time to re-shape our cities

Verde L., Barrea L., Bowman-Busato J., YUMUK V. D., Colao A., Muscogiuri G.

DIABETES-METABOLISM RESEARCH AND REVIEWS , sa.1, 2024 (SCI-Expanded, Scopus)

28. GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?

Muzurovic E., YUMUK V. D., Rizzo M.

JOURNAL OF DIABETES AND ITS COMPLICATIONS , cilt.37, sa.12, 2023 (SCI-Expanded, Scopus)

29. Personalized Physical Activity Programs for the Management of Knee Osteoarthritis in Individuals with Obesity: A Patient-Centered Approach

Zmerly H., Milanese C., El Ghoch M., Itani L., Tannir H., Kreidieh D., et al.

DISEASES , cilt.11, sa.4, 2023 (ESCI, Scopus)

30. A global research priority agenda to advance public health responses to fatty liver disease.

Lazarus J. V., Mark H. E., Allen A. M., Arab J. P., Carrieri P., Noureddin M., et al.

Journal of hepatology , cilt.79, ss.618-634, 2023 (SCI-Expanded, Scopus)

31. Antibody Response to inactive SARS-CoV-2 vaccination in a cohort of elderly patients living with obesity.

Kara Z., Akçin R., Demir A. N., Dinc H. O., Kocazeybek B., Yumuk V. D.

Obesity facts , cilt.16, ss.374-380, 2023 (SCI-Expanded, Scopus)

32. Personalized Nutritional Strategies to Reduce Knee Osteoarthritis Severity and Ameliorate Sarcopenic Obesity Indices: A Practical Guide in an Orthopedic Setting.

Zmerly H., El Ghoch M., Itani L., Kreidieh D., Yumuk V. D., Pellegrini M.

Nutrients , cilt.15, sa.14, 2023 (SCI-Expanded, Scopus)

33. European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis

Muscogiuri G., El Ghoch M., Colao A., Hassapidou M., Yumuk V. D., Busetto L.

OBESITY FACTS , cilt.14, sa.2, ss.222-245, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Şahİn S., HalİloĞlu Ö., Polat Korkmaz Ö., Durcan E., Rekali Şahİn H., Yumuk V. D., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.2, ss.735-742, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

35. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes-a nationwide cross-sectional study (TEMD dyslipidemia study)

BAYRAM F., Sonmez A., Haymana C., SABUNCU T., Dizdar O. S., GÜRKAN E., et al.

LIPIDS IN HEALTH AND DISEASE , cilt.19, sa.1, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Obesity and COVID-19: The Two Sides of the Coin

Dicker D., Bettini S., Farpour-Lambert N., Fruehbeck G., Golan R., Goossens G., et al.

OBESITY FACTS , cilt.13, sa.4, ss.430-438, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. European Association for the Study of Obesity Position Statement on the Global COVID-19 Pandemic

Fruhbeck G., Baker J. L., Busetto L., Dicker D., Goossens G. H., Halford J. C. G., et al.

OBESITY FACTS , cilt.13, sa.2, ss.292-296, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications

Fruhbeck G., Busetto L., Dicker D., Yumuk V. D., Goossens G. H., Hebebrand J., et al.

OBESITY FACTS , cilt.12, sa.2, ss.131-136, 2019 (SCI-Expanded, Scopus)

39. Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study)

Sonmez A., Yumuk V. D., Haymana C., Demirci I., Barcin C., Kiyici S., et al.

OBESITY FACTS , cilt.12, sa.2, ss.167-178, 2019 (SCI-Expanded, Scopus)

40. European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care

Schutz D. D., Busetto L., Dicker D., Farpour-Lambert N., Pryke R., Toplak H., et al.

OBESITY FACTS , cilt.12, sa.1, ss.40-66, 2019 (SCI-Expanded, Scopus)

41. Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)

Sonmez A., Haymana C., BAYRAM F., Salman S., Dizdar O. S., GÜRKAN E., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.146, ss.138-147, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Sarcopenic obesity: Time to meet the challenge

Barazzoni R., Bischoff S. C., Boirie Y., Busetto L., Cederholm T., Dicker D., et al.

CLINICAL NUTRITION , cilt.37, sa.6, ss.1787-1793, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Obesity Management Task Force of the European Association for the Study of Obesity Released "Practical Recommendations for the Post-Bariatric Surgery Medical Management"

BUSETTO L., DICKER D., AZRAN C., BATTERHAM R. L., FARPOUR-LAMBERT N., FRIED M., et al.

OBESITY SURGERY , cilt.28, sa.7, ss.2117-2121, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Sarcopenic Obesity: Time to Meet the Challenge

Barazzoni R., Bischoff S., Boirie Y., Busetto L., Cederholm T., Dicker D., et al.

OBESITY FACTS , cilt.11, sa.4, ss.294-305, 2018 (SCI-Expanded, Scopus)

45. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way

LEITNER D. R., FRUHBECK G., Yumuk V. D., SCHINDLER K., MICIC D., WOODWARD E., et al.

OBESITY FACTS , cilt.10, sa.5, ss.483-492, 2017 (SCI-Expanded, Scopus)

46. A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk

HEBEBRAND J., Holm J., WOODWARD E., Baker J. L., Blaak E., SCHUTZ D. D., et al.

OBESITY FACTS , cilt.10, sa.4, ss.284-307, 2017 (SCI-Expanded, Scopus)

47. A Simple Food-Diverting Operation for Type 2 Diabetes Treatment. Preliminary Results in Humans with BMI 28-32 kg/m².

MELISSAS J., ErenTaskin H. E., PEIRASMAKIS D., DIMITRIADIS E., PAPADAKIS M., Zengin S. U., et al.

Obesity surgery , cilt.27, sa.1, ss.22-29, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Sugar-Sweetened Beverages and Weight Gain in Children and Adults: A Systematic Review from 2013 to 2015 and a Comparison with Previous Studies

Luger M., Lafontan M., Bes-Rastrollo M., Winzer E., Yumuk V. D., Farpour-Lambert N.

OBESITY FACTS , cilt.10, sa.6, ss.674-693, 2017 (SCI-Expanded, Scopus)

49. Perceived Health Status: Is Obesity Perceived as a Risk Factor and Disease?

VISSCHER T. L. S., LAKERVELD J., OLSEN N., KUPERS L., RAMALHO S., KEAVER L., et al.

OBESITY FACTS , cilt.10, sa.1, ss.52-60, 2017 (SCI-Expanded, Scopus)

50. Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management

BUSETTO L., DICKER D., AZRAN C., Batterham R. L., FARPOUR-LAMBERT N., FRIED M., et al.

OBESITY FACTS , cilt.10, sa.6, ss.597-632, 2017 (SCI-Expanded, Scopus)

51. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure

JORDAN J., TOPLAK H., GRASSI G., Yumuk V. D., Kotsis V., ENGELI S., et al.

JOURNAL OF HYPERTENSION , cilt.34, sa.9, ss.1678-1688, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. 2015 Milan Declaration: A Call to Action on Obesity - an EASO Position Statement on the Occasion of the 2015 EXPO

FRUHBECK G., SBRACCIA P., NISOLI E., WOODWARD E., Yumuk V. D., FARPOUR-LAMBERT N. J., et al.

OBESITY FACTS , cilt.9, sa.4, ss.296-298, 2016 (SCI-Expanded, Scopus)

53. Obesity Management in Europe: Current Status and Objectives for the Future

UERLICH M. F., Yumuk V. D., Finer N., BASDEVANT A., VISSCHER T. L. S.

OBESITY FACTS , cilt.9, sa.4, ss.273-283, 2016 (SCI-Expanded, Scopus)

54. 2014 EASO Position Statement on the Use of Anti-Obesity Drugs

TOPLAK H., WOODWARD E., Yumuk V. D., OPPERT J., Halford J. C. G., FRUEHBECK G.

OBESITY FACTS , cilt.8, sa.3, ss.166-174, 2015 (SCI-Expanded, Scopus)

55. Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and early vascular ageing

JORDAN J., Nilsson P. M., Kotsis V., OLSEN M. H., GRASSI G., Yumuk V. D., et al.

JOURNAL OF HYPERTENSION , cilt.33, sa.3, ss.425-434, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. Opportunities for Intervention Strategies for Weight Management: Global Actions on Fluid Intake Patterns

LAFONTAN M., VISSCHER T. L. S., FARPOUR-LAMBERT N., Yumuk V. D.

OBESITY FACTS , cilt.8, sa.1, ss.54-76, 2015 (SCI-Expanded, Scopus)

57. European Guidelines for Obesity Management in Adults

Yumuk V. D., TSIGOS C., FRIED M., SCHINDLER K., BUSETTO L., MICIC D., et al.

OBESITY FACTS , cilt.8, sa.6, ss.402-424, 2015 (SCI-Expanded, Scopus)

58. Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus

SÖZER V., Himmetoglu S., Korkmaz G. G., Kaya Ş., Aydın S., Yumuk V. D., et al.

MINERVA MEDICA , cilt.105, sa.3, ss.237-244, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Obesity: A Gateway Disease with a Rising Prevalence

FRUEHBECK G., Yumuk V. D.

OBESITY FACTS , cilt.7, ss.33-36, 2014 (SCI-Expanded, Scopus)

60. An EASO Position Statement on Multidisciplinary Obesity Management in Adults

Yumuk V. D., FRUERBECK G., OPPERT J. M., WOODWARD E., TOPLAK H.

OBESITY FACTS , cilt.7, sa.2, ss.96-101, 2014 (SCI-Expanded, Scopus)

61. Need for a Paradigm Shift in Adult Overweight and Obesity Management - an EASO Position Statement on a Pressing public Health, Clinical and Scientific Challenge in Europe

FRUEHBECK G., TOPLAK H., WOODWARD E., Halford J. C. G., Yumuk V. D.

OBESITY FACTS , cilt.7, sa.6, ss.408-416, 2014 (SCI-Expanded, Scopus)

62. Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery

Fried M., YUMUK V. D., Oppert J. M., Scopinaro N., Torres A., Weiner R., et al.

OBESITY SURGERY , cilt.24, sa.1, ss.42-55, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. Beyond BMI--phenotyping the obesities.

Blundell J. E., Dulloo A. G., Salvador J., Frühbeck G., Farpour-Lambert N., Fogelholm M., et al.

Obesity facts , cilt.7, sa.5, ss.322-8, 2014 (SCI-Expanded, Scopus)

64. How Things Happen

Fried M., Yumuk V. D.

OBESITY FACTS , cilt.6, sa.5, ss.481-482, 2013 (SCI-Expanded, Scopus)

65. Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery

FRIED M., Yumuk V. D., OPPERT J., SCOPINARO N., TORRES A. J., WEINER R., et al.

OBESITY FACTS , cilt.6, sa.5, ss.449-468, 2013 (SCI-Expanded, Scopus)

66. Obesity: The Gateway to Ill Health - an EASO Position Statement on a Rising Public Health, Clinical and Scientific Challenge in Europe

FRUEHBECK G., TOPLAK H., WOODWARD E., Yumuk V. D., MAISLOS M., OPPERT J.

OBESITY FACTS , cilt.6, sa.2, ss.117-120, 2013 (SCI-Expanded, Scopus)

67. Plasma AGE-peptides and C-peptide in early-stage diabetic nephropathy patients on thiamine and pyridoxine therapy

Cetin E., Civelek S., Andican G., Polizzi F. C., Yumuk V. D., Burcak G.

MINERVA MEDICA , cilt.104, sa.1, ss.93-101, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension

JORDAN J., Yumuk V. D., SCHLAICH M., Nilsson P. M., ZAHORSKA-MARKIEWICZ B., GRASSI G., et al.

JOURNAL OF HYPERTENSION , cilt.30, sa.6, ss.1047-1055, 2012 (SCI-Expanded, Scopus)

69. Prevalence, Pathophysiology, Health Consequences and Treatment Options of Obesity in the Elderly: A Guideline

MATHUS-VLIEGEN E. M. H., BASDEVANT A., FINER N., HAINER V., HAUNER H., MICIC D., et al.

OBESITY FACTS , cilt.5, sa.3, ss.460-483, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

70. Increased DNA-Glycation in Type 2 Diabetic Patients: The Effect of Thiamine and Pyridoxine Therapy

Polizzi F. C., Andican G., Cetin E., Civelek S., Yumuk V. D., Burcak G.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.120, sa.6, ss.329-334, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Criteria for EASO-Collaborating Centres for Obesity Management

TSIGOS C., HAINER V., BASDEVANT A., FINER N., MATHUS-VLIEGEN E., MICIC D., et al.

OBESITY FACTS , cilt.4, sa.4, ss.329-333, 2011 (SCI-Expanded, Scopus)

72. Impact of body mass index on cancer development

YUMUK P. F., DANE F., Yumuk V. D., Yazici D., Ege B., Bekiroglu N., et al.

JOURNAL OF BUON , cilt.13, sa.1, ss.55-59, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

73. Targeting components of the stress system as potential therapies for the metabolic syndrome - The peroxisome-proliferator-activated receptors

Yumuk V. D.

STRESS, OBESITY, AND METABOLIC SYNDROME , cilt.1083, ss.306-318, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Cerebral tuberculosis mimicking intracranial tumour.

Yanardag H., Uygun S., Yumuk V. D., Caner M., Canbaz B.

Singapore medical journal , cilt.46, sa.12, ss.731-3, 2005 (Scopus)

75. What links obesity to cancer?

Yumuk V. D., YUMUK P.

INDOOR AND BUILT ENVIRONMENT , cilt.14, sa.6, ss.527-532, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

76. High prevalence of obesity and diabetes mellitus in Konya, a central Anatolian city in Turkey

Yumuk V. D., HATEMI H. H., TARAKCI T., UYAR N., TURAN N., BAGRIACIK N., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.70, sa.2, ss.151-158, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

77. Celiac disease in an adult Turkish population with type 1 diabetes mellitus

AYGUN C., URAZ S., DAMCI T., OSAR Z., Yumuk V. D., AKDENIZLI E., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.50, sa.8, ss.1462-1466, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Prevalence of obesity in Turkey

Yumuk V. D.

OBESITY REVIEWS , cilt.6, sa.1, ss.9-10, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. Prevalence of Overweight and Obesity in Turkey

Hatemi H., Yumuk V. D., Turan N., ARIK N.

METABOLIC SYNDROME AND RELATED DISORDERS , cilt.1, sa.4, ss.285-290, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

80. Frequency of severe hypoglycemia in patients with non-insulin-dependent diabetes mellitus treated with sulfonylureas or insulin.

Bell D. S., Yumuk V. D.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists , cilt.3, sa.5, ss.281-3, 1997 (Hakemli Dergi) Sürdürülebilir Kalkınma

81. Low incidence of false-positive exercise thallium 201 scintigraphy in a diabetic population

BELL D., Yumuk V. D.

DIABETES CARE , cilt.19, sa.2, ss.185-186, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. BLOOD LIPIDS, DIABETIC COMPLICATIONS AND THE PHYSICIAN ATTITUDES ON DYSLIPIDEMIA TREATMENT; DATA FROM THE TURKISH NATIONWIDE SURVEY OF GLYCEMIC AND OTHER METABOLIC PARAMETERS OF PATIENTS WITH DIABETES

Bayram F., Sonmez A., Haymana C., Sabuncu T., Dizdar O. S., Gurkan E., et al.

86th Congress of the European-Atherosclerosis-Society (EAS), Lisbon, Portekiz, 5 - 08 Mayıs 2018, cilt.275, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Plasma AGE-peptides in diabetic nephropathy patients on thiamine and pyridoxine therapy.

BURÇAK G., Çetin E., Sohtorik C., ANDİCAN G., YUMUK V. D.

34th FEBS Congress., Prag, Çek Cumhuriyeti, 4 - 08 Temmuz 2009, ss.8-215, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. Increased DNA glycation in type 2 diabetic patients: The effects of thiamine and pyridoxine therapy.

BURÇAK G., Sohtorik C., Çetin E., ANDİCAN G., YUMUK V. D.

34th FEBS Congress., Prag, Çek Cumhuriyeti, 4 - 11 Temmuz 2009, ss.8-216, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

4. Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease

Gelisgen R., Cimen B., Yumuk V., Bolayirli M., Hacibekiroglu M., Burcak G.

32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS), Vienna, Avusturya, 7 - 12 Temmuz 2007, cilt.274, ss.265, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Obesity and cancer

Yumuk V. D.

15th European Congress on Obesity, Budapest, Macaristan, 22 - 25 Nisan 2007, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease

Cimen B., Gelisgen R., Andican G., Yumuk V., Bolayirli M., Hacibekiroglu M., et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.209, (Özet Bildiri) Sürdürülebilir Kalkınma

7. The comorbidity of personality disorders among individuals with obesity and their relation to self-esteem in a Turkish clinical sample

Yalug I., Erdogan A., Ozdemir A., Ozmen M., Yumuk V. D.

13th European Congress on Obesity, Prague, Çek Cumhuriyeti, 26 - 29 Mayıs 2004, cilt.28, (Özet Bildiri) Sürdürülebilir Kalkınma

Kitaplar 2

1. obezite tedavisi

Bozdoğan Polat S. H., Yumuk V. D.

bariyatrik ve metabolik cerrahi genel prensipler ve yenilikler II, mustafa taşkın,halit eren taşkın,seniyye ülgen zengin, Editör, Istanbul University-Cerrahpaşa University Press (IUC University Press), İstanbul, ss.51-58, 2023

2. Obezitenin Patofizyolojisi

Bozdoğan Polat S. H., Yumuk V. D.

Bariyatrik ve Metabolik Cerrahi Genel Prensipler ve Yenilikler II, mustafa taşkın,halit eren taşkın,seniyye ülgen zengin, Editör, Istanbul University-Cerrahpaşa University Press (IUC University Press), İstanbul, ss.132-140, 2023

Metrikler

Yayın

105

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

5806

H-İndeks (WoS)

Atıf (Scopus)

6371

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim